ARTICLE

FindCenter AddIcon

New Clues Found in Understanding Near-Death Experiences

By Robert Matone — 2019

Research finds parallels to certain psychoactive drugs.

Read on www.scientificamerican.com

FindCenter Post-Image

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.

Article
Andrew Jacobs
2021
FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Article
Maureen Meehan
2017
FindCenter AddIcon
FindCenter Post-Image

Maps Founder Rick Doblin: You’re Never Too Old for a Psychedelic Experience

Rick Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, as a “non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.”*.

Article
Abbie Rosner
2020
FindCenter AddIcon

EXPLORE TOPIC

Near-Death Experience